Skip to main content

DOJ Issues Subpoena To Philips Over Sleep Apnea Devices

DOJ Issues Subpoena To Philips Over Sleep Apnea Devices

DOJ Issues Subpoena To Philips Over Sleep Apnea Devices

Introduction

The U.S. Department of Justice has subpoenaed Royal Philips NV over the recall of defective CPAP sleep apnea machines and respirators, which are alleged of causing severe problems to the users.

Philips Respironics and its U.S. subsidiaries were handed over the subpoena on April 8. The sleep machines used by millions of Americans are alleged of releasing toxic sound abatement foam particles and debris, which go directly into the pathways and lungs of individuals.

In June 2021, the company recalled millions of Philips DreamStation, CPAP and BiPAP machines as the manufacturer admitted that sound abatement foam made from polyester (PE-PUR) might break down and degrade, eventually releasing black particles or debris directly into the sleep apnea machine’s air pathway. It would expose the users to some toxic gases and chemicals.

The company now faces several product liability lawsuits and class action claims against its Philips CPAP machines. The lawsuits are brought forward by hundreds of former users reporting cases of cancer, lung damage and other respiratory problems.

The FDA declared in the last month that Philips CPAP recall notifications failed to meet federal requirements. As per the agency's report, the company lapsed in informing the CPAP machine users about the health risks. The investigators of FDA even suggested that Philips was aware of the sound abatement foam problem for years, yet it did not issue warnings to the users and failed to follow up the complaints.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Baltimore Wins $266M in Opioid Case Against Drug Distributors

Categories: Opioids

Baltimore has secured a $266 million victory in its lawsuit against major drug distributors McKesson and Cencora (formerly AmerisourceBergen), accusing them of fueling the…

DOJ Opposes JnJ’s Texas Bankruptcy Move in Talc Lawsuit Cases

Categories: Talcum

The U.S. Department of Justice (DOJ) recently opposed Johnson & Johnson’s latest attempt to use bankruptcy to resolve tens of thousands of…

First Valsartan Bellwether Trial to Focus on Cancer Lawsuits

Categories: Valsartan

The U.S. District Judge overseeing…

Demand Letter or Medical Record Review?     
Free Trials + 10% Discount!